Healthy Aging

Treating Skin Disorders From the Inside Out: An Interview with Dr. Julia Hunter

By Roby Mitchell, MD / Contributing Writer - Vol. 11, No. 4. , 2010

Many dermatologists will lip-service the ideas that, “beauty begins from within,” and “Skin health is a reflection of overall health.” But very few of them practice that way. Dr. Julia Hunter, a holistic dermatologist in Los Angeles, is a rare exception. In this interview with Dr. Roby Mitchell, Dr. Hunter shares insight on connections between the skin and the gut, the role of vitamin C in skin care, skin care ingredients to avoid, and much more.

Telomeres, Aging, & Disease Prevention: Do Telomere-Targeted Treatments Have a Role in Clinical Practice?

By Stephen Holt, MD, PhD | Contributing Writer - Vol. 11, No. 3. , 2010

Telomeres—segments of chromosomes that prevent aberration or loss of genetic information during cell division—are among the hottest research topics these days, and they’ve become the focus of “anti-aging” and chronic disease prevention strategies. Like many areas of genetic research, the work on telomeres raises as many questions as it answers. Anti-aging specialist Dr. Stephen Holt explores the many nuances of telomere and telomerase research, offering his own clinically tested recommendations.

Getting to the Eye of the Storm In People with Diabetes

By Fred Pescatore, MD | Contributing Writer - Vol. 11, No. 2. , 2010

Diabetic retinopathy is the leading cause of new cases of vision loss in adults between ages 20 and 74, and more than 40% of people newly diagnosed with diabetes already have some level of retinal damage. The good news is that the disease process can be prevented or arrested by reducing sugar intake, regular exercise and targeted use of nutraceuticals like chromium picolinate, lutein, zeaxanthin, and Pycnogenol.

Assessing & Treating Bone Loss: Seven Tips For Improving Outcomes

By Meg Sinclair | Contributing Writer - Vol. 11, No. 1. , 2010

Because of its very slow, insidious nature, osteoporosis is challenging to evaluate. Long-term daily drug therapy carries significant risk of side effects, a big price tag, and major compliance challenges. The key is to determine early on who is at greatest risk for fracture, and who truly needs intensive therapy.

To Prevent Osteoporosis, Concentrate On Vitamin D, Not Bisphosphonates

By August West | Contributing Writer - Vol. 11, No. 1. , 2010

The evidence supporting widespread use of bisphosphonate drugs for preventing osteoporosis fractures is pretty weak, while the data in favor of vitamin D supplementation is increasingly strong. Doctors who advocate “evidence-based medicine” need to rethink the role of drugs in treating women with osteoporosis.